Gilead Sciences Inc. (GILD)
NASDAQ · Healthcare
Gilead Sciences Inc. Total Liabilities 2007–2025
Gilead Sciences Inc. annual total liabilities history from 2008 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Gilead Sciences Inc. total liabilities as of December 31, 2025: 36.32B, a 8.43% decrease year-over-year.
- Gilead Sciences Inc. total liabilities for 2025 were 36.32B, a 8.43% decrease from 2024.
- Gilead Sciences Inc. total liabilities for 2024 were 39.66B, a 0.95% increase from 2023.
- Gilead Sciences Inc. total liabilities for 2023 were 39.29B, a 6.29% decrease from 2022.
- Gilead Sciences Inc. total liabilities for 2022 were 41.93B.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Gilead Sciences Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $36,320 |
| 2024 | $39,665 |
| 2023 | $39,292 |
| 2022 | $41,931 |
| 2021 | $46,883 |
| 2020 | $50,205 |
| 2019 | $39,102 |
| 2018 | $42,288 |
| 2017 | $49,841 |
| 2016 | $38,090 |
| 2015 | $33,182 |
| 2014 | $19,238 |
| 2013 | $11,209 |
| 2012 | $11,937 |
| 2011 | $10,564 |
Gilead Sciences Inc. Total Liabilities — FAQ
Gilead Sciences Inc. (GILD) total liabilities over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GILD's total liabilities history?
The chart and table above show Gilead Sciences Inc.'s total liabilities by year and by quarter, including the growth rate.